Abstract:Developed as novel protecting groups for solid-phase peptide synthesis, aryl boronate ester based amino acid building blocks exhibit many advantages over Alloc/Allyl groups and other traditional protecting groups due to their environmental-friendly deprotection conditions and high deprotection efficiency. These protecting groups have been found to exhibit all of the chemical properties compatible to the standard Fmoc(9-Fluorenylmethyloxycarbonyl) solid-phase peptide synthesis and to be orthogonal to other protection groups, such as Bu-t (tert-butyl), pbf (2,2,4,6,7-penta-methyldihydroben zofuran-5-sulfonyl), Trt (trityl) and Boc (t-Butyloxy carbonyl). In this paper, the aryl bronate ester protected Asp was employed to synthesize a lactam-bridged bicyclic peptide, BI-32169 ([Gly-Leu-Pro-Trp-Gly-Cys-Pro-Ser-Asp]-Ile-Pro-GlyTrp-Asn-Thr-Pro-Trp-Ala-Cys), which is a human glucagon receptor peptide inhibitor, via on-resin cyclization and solution phase oxidative folding. First of all, the Fmoc-Asp(pDobb)-OH (pDobb, dihydroxyborylbenzyl pinacol ester) was successfully synthesized via esterification between Fmoc-Asp-(OBu)-Bu-t and 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) followed by deprotection of Bu-t with trifluoroacetic acid. Subsequently, the fully protected linear peptide was obtained by incorporating Fmoc-Asp(pDobb)-OH into peptide backbone through standard SPPS using HCTU/DIPEA as the coupling reagent and base. The following release of pDobb group on Asp side chain and deprotection of the N-terminal Fmoc group on solid support provided the linear peptide containing a free Asp residue and an N-terminal amino group. The critical cyclization step was accomplished on resin using PyAOP/HOAt/NMM, followed by resin cleavage and global deprotection with TFA/Phenol/Water/TIPS to give the monocyclic peptide. Finally, the intramolecular disulfide bond was formed through oxidative folding in an aqueous environment with 10% DMSO to provide the final bicyclic target, BI-32169, with a total yield about 27%. In summary, the human glucagon receptor peptide inhibitor BI-32169 was successfully synthesized utilizing an aryl boronate ester based amino acid building block via an on-resin cyclization and solution phase oxidative folding strategy. This convenient and efficient synthetic route could provide a way for chemical total synthesis of BI-32169 and other analogues.

Synthesis of the Key Intermediate of SM-406 (xevinapant) and Its Analogues.

Synthesis of Conformationally Constrained Dipeptide Mimetics with Azabicyclo[4,3,0]nonanone and Azabicyclo[5,3,0]decanone Scaffolds

Synthesis of Key Intermediate of Diazepinomicin

Development of XIAP Antagonists Based on De Novo 8,5-Fused Bicyclic Lactams.

Design, Synthesis and Evaluation of 3-(2-aminoheterocycle)-4-benzyloxyphenylbenzamide Derivatives As BACE-1 Inhibitors

Design, Synthesis and Biological Evaluation of Novel Imidazolone Derivatives As Dipeptidyl Peptidase 4 Inhibitors.

TDPBP Derivative Aiding Liquid-Phase Synthesis Strategy and ACE Inhibitory Structure-activity Relationship of Anti-SARS Octapeptide

Efficient Synthesis of ESI-09, A Novel Non-cyclic Nucleotide EPAC Antagonist.

Synthesis of Two Dipeptidyl Peptidase Ⅳ Inhibitors of α-Amino Acid Derivatives

Dmab/ivDde Protected Diaminodiacids for Solid-Phase Synthesis of Peptide Disulfide-Bond Mimics

Pdobz/pdobb Protected Diaminodiacid As a Novel Building Block for Peptide Disulfide-Bond Mimic Synthesis

Diaminodiacid-based solid-phase synthesis of peptide disulfide bond mimics.

Efficient Syntheses of (-)-crinine and (-)-aspidospermidine, and the Formal Synthesis of (-)-minfiensine by Enantioselective Intramolecular Dearomative Cyclization.

Synthesis and Biological Evaluation of N-Aminoimidazolidin-2-one-Containing Angiotensin-(1–7) Peptidomimetics

Synthesis and Biological Evaluation of Analogues of the Marine Cyclic Depsipeptide Obyanamide.

Synthesis and evaluation of disulfide-rich cyclic α-conotoxin [S9A]TxID analogues as novel α3β4 nAChR antagonists

Efficient Synthesis of Bicyclic Peptide BI-32169 Utilizing a Novel Aryl Boronate Ester Protecting Group

An Efficient Stereoselective Synthesis of Six Stereoisomers of 3, 4-Diaminocyclohexane Carboxamide As Key Intermediates for the Synthesis of Factor Xa Inhibitors

A Convenient and Efficient Synthesis of Dipeptidyl Benzoxaboroles and Their Peptidomimetics

Practical Synthesis of ECH and Epoxyquinols A and B from (-)-shikimic Acid.

Total Syntheses of Streptamidine and Klebsazolicin Using Biomimetic On‐Resin Ring‐Closing Amidine Formation